China SXT Pharmaceuticals, Inc. (SXTC)
5.01
+4.17 (496.43%)
Inactive · Last trade price
on Feb 25, 2025
China SXT Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2016 |
| Net Income | -3.1 | -5.93 | -5.74 | -2.75 | -10.29 | Upgrade
|
| Depreciation & Amortization | 0.2 | 0.25 | 0.32 | 0.35 | 0.33 | Upgrade
|
| Other Amortization | 0.29 | 0.34 | 0.03 | 1.12 | 3.42 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.42 | 0.35 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.35 | 0.55 | 2.33 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.28 | 2.88 | 0.48 | 1.21 | 0.04 | Upgrade
|
| Other Operating Activities | -0 | 0.07 | 0.94 | 0.37 | 5.48 | Upgrade
|
| Change in Accounts Receivable | -0.32 | 0.91 | 0.83 | -0.52 | 0.1 | Upgrade
|
| Change in Inventory | -0.19 | 0.41 | 0.3 | -0.3 | 0.19 | Upgrade
|
| Change in Accounts Payable | -0.03 | 0.01 | -0.02 | -0.62 | 0.3 | Upgrade
|
| Change in Income Taxes | 0 | 0.03 | -0.03 | 0.09 | -0.02 | Upgrade
|
| Change in Other Net Operating Assets | 0.16 | 0.06 | 0.83 | -0.26 | 1.37 | Upgrade
|
| Operating Cash Flow | -1.93 | -0.08 | 0.27 | -1.32 | 0.93 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 290.58% | Upgrade
|
| Capital Expenditures | -0.01 | -0.07 | -0.06 | -0.09 | -0.41 | Upgrade
|
| Investment in Securities | - | - | - | -8.85 | - | Upgrade
|
| Other Investing Activities | 0.03 | 0.06 | 0.02 | 3.13 | -3.59 | Upgrade
|
| Investing Cash Flow | 0.03 | -0.01 | -0.05 | -5.81 | -5.5 | Upgrade
|
| Short-Term Debt Issued | 1.06 | 3.72 | 2.8 | 12.53 | - | Upgrade
|
| Long-Term Debt Issued | 0.43 | 0.31 | - | - | 10 | Upgrade
|
| Total Debt Issued | 1.5 | 4.03 | 2.8 | 12.53 | 10 | Upgrade
|
| Short-Term Debt Repaid | -3.93 | -2.83 | -3.81 | - | -3.18 | Upgrade
|
| Long-Term Debt Repaid | -0.08 | -0.03 | -0.03 | -0.12 | -1.2 | Upgrade
|
| Total Debt Repaid | -4.01 | -2.85 | -3.85 | -0.12 | -4.38 | Upgrade
|
| Net Debt Issued (Repaid) | -2.51 | 1.18 | -1.04 | 12.41 | 5.62 | Upgrade
|
| Issuance of Common Stock | - | 2.19 | 3.12 | - | - | Upgrade
|
| Other Financing Activities | -0.11 | -0.43 | -0.48 | - | -2.6 | Upgrade
|
| Financing Cash Flow | -2.62 | 2.94 | 1.6 | 12.41 | 3.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.77 | -1.05 | 0.39 | 0.78 | -0.47 | Upgrade
|
| Net Cash Flow | -5.29 | 1.8 | 2.21 | 6.07 | -2 | Upgrade
|
| Free Cash Flow | -1.94 | -0.15 | 0.21 | -1.41 | 0.53 | Upgrade
|
| Free Cash Flow Margin | -100.34% | -7.68% | 7.91% | -29.50% | 10.22% | Upgrade
|
| Free Cash Flow Per Share | -17.85 | -4.54 | - | - | - | Upgrade
|
| Cash Interest Paid | 0.02 | 0.01 | 0 | 0.01 | 0.29 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.02 | 0 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -1.22 | 1.78 | 2.31 | 2.57 | -3.48 | Upgrade
|
| Unlevered Free Cash Flow | -1.17 | 1.75 | 2.31 | 2.15 | -4.81 | Upgrade
|
| Change in Net Working Capital | 0.41 | -4.3 | -2.96 | -3.27 | 3.89 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.